Dr. Barry W. Brown is the Director of the Cancer Information Systems Resource (CISR), which is housed in the Department of Biomathematics and is located in the Houston Main Building. This resource provides scientific computational capabilities to meet the diverse needs of peer-reviewed and funded M.D. Anderson researchers. Those needs are identified through collaborations with these investigators. Members of the CISR are well qualified to provide computer code meeting these needs because they are familiar with numeric and computational methods, sources of quality computer code, and general quantitative and statistical methodology and because they understand standards for good code. The primary computational servers for this Resource are two fast DEC Alpha machines running Unix. Each member of the Resource accesses these machines via a dedicated PC or Macintosh computer. The software used by the Resource includes a variety of statistical systems, symbolic and numeric mathematical systems, and programming aids. The resource's software is widely used not only by CISR members but also by the Biostatistical Resource Group (BRG), clinical and basic-science investigators at M.D. Anderson, and cancer and other biomedical researchers. The software the CISR develops is posted on the World Wide Web and submitted to many archives from which it is freely available. The CISR has been continuously funded from the Cancer Center Support Grant (CCSG) since 1975, when M.D. Anderson when received its first CCSG, and continues to provide invaluable (and otherwise unavailable) services to investigators with peer-reviewed grants.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016672-25S1
Application #
6347262
Study Section
Project Start
2000-08-30
Project End
2001-06-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2000
Total Cost
$254,104
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Grossberg, Aaron J; Mohamed, Abdallah S R; Elhalawani, Hesham et al. (2018) Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data 5:180173
Lu, Zhimin; Hunter, Tony (2018) Metabolic Kinases Moonlighting as Protein Kinases. Trends Biochem Sci 43:301-310
Beadnell, Thomas C; Nassar, Kelsey W; Rose, Madison M et al. (2018) Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer. Oncogenesis 7:23
Chen, Xiuhui; Mangala, Lingegowda S; Rodriguez-Aguayo, Cristian et al. (2018) RNA interference-based therapy and its delivery systems. Cancer Metastasis Rev 37:107-124
Kono, Miho; Fujii, Takeo; Matsuda, Naoko et al. (2018) Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis. J Cancer 9:3640-3646
Khouri, Issa F; Fernandez Curbelo, Irina; Turturro, Francesco et al. (2018) Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies. Clin Cancer Res 24:1011-1018
Chen, Tsai-Yu; Lee, Sung-Hun; Dhar, Shilpa S et al. (2018) Protein arginine methyltransferase 7-mediated microRNA-221 repression maintains Oct4, Nanog, and Sox2 levels in mouse embryonic stem cells. J Biol Chem 293:3925-3936
Ng, Chaan S; Wei, Wei; Ghosh, Payel et al. (2018) Observer Variability in CT Perfusion Parameters in Primary and Metastatic Tumors in the Lung. Technol Cancer Res Treat 17:1533034618769767
Pan, Tianhong; Lin, Song-Chang; Yu, Kai-Jie et al. (2018) BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation. Neoplasia 20:32-43
Moore, Amanda R; Ran, Leili; Guan, Youxin et al. (2018) GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma. Cell Rep 22:2455-2468

Showing the most recent 10 out of 12418 publications